They further created macrophage-specific CD39 knockout mice and discovered that CD73 expression in HCC cells and CD39 expression in macrophages could impair the function of CD8 + T cells and induce anti-PD1 resistance by activating the eATP-adenosine pathway. Here, ENTPD1 is linked to hepatocellular carcinoma.